Genesco (GCO) Misses Q3 EPS by 10c, Trims FY EPS Guidance

Genesco (NYSE: GCO) reported Q3 EPS of $1.02, $0.10 worse than the analyst estimate of $1.12. Revenue for the quarter came in at $717 million versus the consensus estimate of $706.58 million.

GUIDANCE:

Genesco sees FY2018 EPS of $3.05-$3.35, versus the consensus of $3.39.

• This guidance assumes comparable sales in the range of -1% to 1% for the full year.

For earnings history and earnings-related data on Genesco (GCO) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Barclays Upgrades Schott Pharma AG (1SXP:GR) to Overweight
• InspireMD (NSPR) Tops Q2 EPS by 1c